Implementation of Guidelines for Hpv-related Anal Cancer Screening

New national HIV guidelines now recommend routine screening for anal HPV disease to prevent anal cancer in certain population. Increasing rates of anal cancer have been identified among certain populations including those living with HIV, men who have sex with men, people with iatrogenic immunosuppression, and people with other HPV-related disease. Anal cytology (“pap”) is a simple test which does not require special training or equipment, but the test is limited by low sensitivity and specificity. Abnormal findings follow an algorithm developed from that of HPV-associated cervical dysplasia, but with significant differences. The faculty will review the new guidelines and the supporting epidemiologic and clinical data, provide a brief explanation of high resolution anoscopy (HRA) and anal dysplasia treatment, and demonstrate how to perform anal cytology.